Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study.

Cancers (Basel) · 2025 · PMC12346639 · PMID 40805161

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

This association, however, did not reach statistical significance ( p = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.